Harvard Bioscience (HBIO) announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. DeNelsky will also serve on the Board’s Nominating and Governance Committee.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- Harvard Bioscience Offers CFO $100K Retention Bonus
- Harvard Bioscience at Risk of Nasdaq Delisting: Implications for Investors and Business Stability
- Harvard Bioscience Reports Q2 2025 Financial Results
- Harvard Bioscience Surpasses Revenue Guidance Amid Challenges
- Harvard Bioscience Amends Credit Agreement with Lenders